CCG is hosting a 1-day meeting focusing on benefits of computer-aided ligand and structure-based drug design techniques for medicinal chemists.
Short hands-on workshops in the morning will be followed by scientific presentations in the afternoon. The meeting will end with a social reception.
Please note that space is limited so early registration is recommended.
08:00-08:30 | Morning Coffee Registration (check-in and badge pick-up) |
08:30-10:00 |
Pharmacophore Modeling / Docking / Fragment-based Design / Scaffold Replacement / R-Group Screening / Project Search / Protein-Ligand Interaction Fingerprints |
10:00-10:30 | Morning Break |
10:30-12:00 |
R-Group Profiles and Analysis / MOEsaic / MMP Analysis / Descriptor Calculations / Conformational Searching / Molecular Alignments / Pharmacophore Modeling and Searching / Diversity Analysis |
12:00-13:00 | Lunch Break |
13:00-13:25 | Registration (check-in and badge pick-up) |
13:25-13:30 |
13:30-14:00 | Andreas Goutopoulos, Senior Director- Chemistry, EMD Serono, Inc. |
14:00-14:30 | Matt Lucas, Director of Chemistry, Yumanity Therapeutics |
14:30-15:00 | Chris Yates, Director of Medicinal Chemistry, Viamet Pharmaceuticals |
15:00-15:30 | Al Ajamian, Director, Chemical Computing Group |
15:30-16:00 | Afternoon Break |
16:00-16:30 | Sean Brown, Principal Scientist, Amgen |
16:30-17:00 | Jörg Bentzien, Principal Scientist, FORMA Therapeutics, Inc. |
17:00-17:30 | Ravi Kurumbail, Research Fellow, Pfizer |
17:30-18:00 | Edward J. Hennessy, Associate Principal Scientist, AstraZeneca |
18:00-18:15 |
18:15-19:15 | Social Reception |
There is no cost to attend but pre-registration is required as seats are limited. Registrations will be processed and accepted on a first-come, first-serve basis.